Acknowledging the kind of traction gained by this market, recently published a study report by industry data analytics asserts the global Caps and Closures for Non-carbonated Beverages Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 13.8% during the review period (2022 to 2027).
Therapeutic Cancer Vaccines Market Overview
The cancer vaccines market is expected to experience a significant growth during the forecast period, owing to rise in demand for novel cancer vaccine products, increase in occurrence of HPV infections, surge in public awareness toward cancer diseases, and rise in investments by government & private organizations for manufacture of new cancer vaccines. Moreover, rise in adoption rates of defensive and therapeutic vaccines, technological advancements in cancer vaccines, increase in number of cancer cases, and launch of novel cancer injections further boost the cancer serums market growth. Though, high cost for developing cancer vaccines and longer time span required for manufacturing a single vaccine are anticipated to restrict the market growth. Furthermore, growth in transition from prophylactic to therapeutic cancer injections is expected to offer lucrative opportunities in the near future.Cancer vaccines that are therapeutic are drugs that act as biological response modifiers. These biological response modifiers help the body's immune system combat cancer by boosting it. Cancer vaccines are divided into two categories: preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccinations are given to healthy people to help them from getting cancer. Cancer patients are given therapeutic cancer vaccines to boost their immune system's ability to combat the disease. Cancer vaccinations can be given intravenously (IV) to both children and adults.
The report aspects discussed the profile of the top manufacturers of the global Therapeutic Cancer Vaccines market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Therapeutic Cancer Vaccines Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Who are the Major Players in Therapeutic Cancer Vaccines Market?
The global Therapeutic Cancer Vaccines includes identification and analysis of the various market participants competing in the global market. Prominent competitors include Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna, Northwest Biotherapeutics, VAXIMM and others.
Industry News and Updates:
April 8, 2022: Agenus Presents Data on AGEN1571 (anti-ILT2) at AACR and Announces IND Clearance
Agenus Inc. (Nasdaq: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate immune response to cancers and infections, announced the first presentation of preclinical data from AGEN1571 – a novel anti-ILT2 antibody designed to modulate tumor-associated macrophages, T, NK and NKT cells.
March 2, 2022 : Bayer announced the commercial registrations from the EPA for the traits that will enable the commercialization of its newest corn product, VT4PRO™ with RNAi Technology, in the United States. VT4PRO™ Technology* will provide US farmers an additional option within the already-strong Bayer corn product portfolio to help control troublesome above-ground and below ground pests.
What are the major Applications, Types and Regions for Therapeutic Cancer Vaccines Market?
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
- Whole Cell Vaccine
- Antigen Vaccine
- Non-specific and Cytokine Strategies
- Others
By Application, it is segmented into
- Bladder Cancer
- Brain Tumors
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Cervical Cancer
- Others
Therapeutic Cancer Vaccines Market Regional Analysis
Asia-Pacific presents lucrative opportunities for key players operating in the Therapeutic cancer vaccines market. Furthermore, rising demand for cancer vaccines, increased funding from both the public and private sectors to develop novel therapeutic cancer vaccines, an increase in the number of hospitals and diagnostic centres with advanced medical facilities, and the presence of a large population base all contribute to the market's growth.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
The Therapeutic Cancer Vaccines Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Therapeutic Cancer Vaccines Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Therapeutic Cancer Vaccines Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2028 CAGR
|
CAGR of 13.8% during the review period (2022 to 2027).
|
By Type
|
- Whole Cell Vaccine
- Antigen Vaccine
- Non-specific and Cytokine Strategies
- Others
|
By Application
|
- Bladder Cancer
- Brain Tumors
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Cervical Cancer
- Others
|
By Companies
|
Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna, Northwest Biotherapeutics
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
135
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Therapeutic Cancer Vaccines Report
- Evaluate Therapeutic Cancer Vaccines market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.
- Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.
- Analyze the sales and distribution channels across geographies to enhance top-line revenues.
- Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Therapeutic Cancer Vaccines market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.
- Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
Frequently Asked Question -
What is the study period of this market?
The Therapeutic Cancer Vaccines Market is studied from 2022-2027.
Who are the Prime players in the Therapeutic Cancer Vaccines Market?
Antigenics, Asterias Biotherapeutics, Avax Technologies, Bayer, GlaxoSmithKline, Mayo Clinic, Merck, Moderna, Northwest Biotherapeutics
Which region held the largest share in the Therapeutic Cancer Vaccines Market?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant types of Therapeutic Cancer Vaccines Market?
Whole Cell Vaccine, Antigen Vaccine, Non-specific and Cytokine Strategies
What are the major applications of Therapeutic Cancer Vaccines Market?
Bladder Cancer, Brain Tumors, Breast Cancer, Lung Cancer, Prostate Cancer, Cervical Cancer, Others
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
